UBS Group’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

UBS Group’s Portfolio AMSGP Stock Details AMSGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-525	Closed	-$67K	–	8366
2016 Q3	$67K	Buy	525 +110	+27%	+$14.3K	﹤0.01%	5284
2016 Q2	$60K	Buy	415 +13	+3%	+$1.89K	﹤0.01%	5387
2016 Q1	$57K	Buy	402 +104	+35%	+$14K	﹤0.01%	5412
2015 Q4	$43K	Sell	298 -300	-50%	-$45.2K	﹤0.01%	5959
2015 Q3	$88K	Buy	+598	New	+$90.7K	﹤0.01%	5347

UBS Group's AMSGP Position: Q4 2016 in Review

UBS Group sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 525 shares — an estimated $67K sold.

UBS Group first reported a position in AMSGP in Q3 2015 and held it in 5 quarters. The position peaked at $88K in Q3 2015. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

UBS Group reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
UBS Group sold 525 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $67K.
UBS Group first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q3 2015 and held it in 5 quarters.
UBS Group's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $88K in Q3 2015.
0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.